Study finds novel gene correction model for epidermolysis bullosa

A research team led by pediatric blood and marrow transplantation experts Mark Osborn, Ph.D. and Jakub Tolar, M.D., Ph.D. from the Masonic Cancer Center, University of Minnesota, have discovered a remarkable new way to repair genetic defects in the skin cells of patients with the skin disease epidermolysis bullosa.

http://medicalxpress.com/news/2013-06-gene-epidermolysis-bullosa.html